Redoblado, Xyryll Kaye E.

HRN: 16-16-91  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
06/28/2023
07/02/2023
ORAL
3.2
BID
Pcap
06/28/2023
CEFTRIAXONE 1G (VIAL)
06/28/2023
07/04/2023
IV
2.5g
OD
Pcap
Waiting Final Action 
06/28/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
06/28/2023
07/02/2023
PO
3.2mL
BID
Pneumonia

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: